Pla2g16 phospholipase mediates gain-of-function activities of mutant p53 S Xiong, H Tu, M Kollareddy, V Pant, Q Li, Y Zhang, JG Jackson, YA Suh, ... Proceedings of the National Academy of Sciences 111 (30), 11145-11150, 2014 | 87 | 2014 |
TP53 copy number and protein expression inform mutation status across risk categories in acute myeloid leukemia M Tashakori, T Kadia, S Loghavi, N Daver, R Kanagal-Shamanna, ... Blood, The Journal of the American Society of Hematology 140 (1), 58-72, 2022 | 53 | 2022 |
Tissue‐specific and age‐dependent effects of global Mdm2 loss Y Zhang, S Xiong, Q Li, S Hu, M Tashakori, C Van Pelt, MJ You, L Pageon, ... The Journal of pathology 233 (4), 380-391, 2014 | 43 | 2014 |
P53 protein overexpression in de novo acute myeloid leukemia patients with normal diploid karyotype correlates with FLT3 internal tandem duplication and worse … R Assi, HD Gur, S Loghavi, SN Konoplev, M Konopleva, N Daver, ... American journal of hematology 93 (11), 1376-1383, 2018 | 17 | 2018 |
Development of TP53 mutations over the course of therapy for acute myeloid leukemia Y Alwash, JD Khoury, M Tashakori, R Kanagal‐Shamanna, N Daver, ... American journal of hematology 96 (11), 1420-1428, 2021 | 15 | 2021 |
Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases H Fang, SA Wang, JD Khoury, S El Hussein, DH Kim, M Tashakori, ... Haematologica 107 (9), 2232, 2022 | 13 | 2022 |
Pan-RAF Inhibition Shows Anti-Leukemic Activity in RAS-Mutant Acute Myeloid Leukemia Cells and Potentiates the Effect of Sorafenib in Cells with FLT3 Mutation JD Khoury, M Tashakori, H Yang, S Loghavi, Y Wang, J Wang, S Piya, ... Cancers 12 (12), 3511, 2020 | 11 | 2020 |
Next-generation scholarship: rebranding hematopathology using Twitter: the MD Anderson experience S El Hussein, JD Khoury, KA Lyapichev, M Tashakori, M Khanlari, ... Modern Pathology 34 (5), 854-861, 2021 | 10 | 2021 |
Pleomorphic fibroma of the skin with MDM2 immunoreactivity: a potential diagnostic pitfall. M Tashakori, J Pimentel, BE Howitt, J Sanchez, S Michalowski, D Chitale, ... Journal of Cutaneous Pathology, 2017 | 6 | 2017 |
p53 Activity Dominates That of p73 upon Mdm4 Loss in Development and Tumorigenesis M Tashakori, Y Zhang, S Xiong, MJ You, G Lozano Molecular Cancer Research 14 (1), 56-65, 2016 | 6 | 2016 |
B acute lymphoblastic leukemia arising during maintenance therapy for multiple myeloma M Tashakori, JD Khoury Blood, The Journal of the American Society of Hematology 136 (23), 2720-2720, 2020 | 4 | 2020 |
Differential characteristics of TP53 alterations in pure erythroid leukemia arising after exposure to cytotoxic therapy M Tashakori, W Wang, TM Kadia, NG Daver, G Montalban-Bravo, ... Leukemia research 118, 106860, 2022 | 3 | 2022 |
Mantle cell lymphoma involving tonsils: a clinicopathologic study of 83 cases M Tashakori, DH Kim, R Kanagal-Shamanna, F Vega, RN Miranda, P Jain, ... Human pathology 118, 60-68, 2021 | 3 | 2021 |
Hematogones with light chain restriction: A potential diagnostic pitfall when using flow cytometry analysis to assess bone marrow specimens S El Hussein, W Wang, SA Wang, H Fang, S Garces, M Tashakori, ... Leukemia research 111, 106704, 2021 | 2 | 2021 |
From the archives of MD Anderson Cancer Center: A case of concurrent follicular lymphoma and Langerhans cell sarcoma with a review of the literature M Tashakori, B Thakral, G Tang, JD Khoury, LJ Medeiros Annals of Diagnostic Pathology 52, 151720, 2021 | 2 | 2021 |
Colonic myeloid sarcoma with mutated NPM1 manifesting with ulceration M Tashakori, JD Khoury EJHaem 3 (2), 555, 2022 | 1 | 2022 |
A “Double-Hit” lymphoblastoid transformation of follicular lymphoma in the eye M Tashakori, JL Carey, KV Inamdar, M Madhu P American Society for Clinical Pathology 146 (Issue suppl 1, 1 September 2016), 2016 | 1 | 2016 |
Role of tumor necrosis factor gene polymorphism (-308 and-238) in colorectal cancer susceptibility M Tashakori, B Noorinayer, F Khatami, MR Zali ANNALS OF ONCOLOGY 19, I30-I31, 2008 | 1 | 2008 |
Association of single nucleotide polymorphism in the promoter of TNF-alpha gene (-308 G> A) with susceptibility to colorectal cancer among Iranian population M Tashakori, B Noorinayer, M Tashakori ANNALS OF ONCOLOGY 19, 82-82, 2008 | 1 | 2008 |
Potential genetic mechanisms driving B/myeloid conversion in patients with follicular lymphoma and Langerhans cell neoplasms M Tashakori, LJ Medeiros Leukemia & Lymphoma, 1-5, 2024 | | 2024 |